Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 23 January 1998:
Vol. 279. no. 5350, p. 472
DOI: 10.1126/science.279.5350.472a
Prev | Table of Contents | Next

News & Comment

SCIENCE AND COMMERCE:
'Fountain of Youth' Lifts Biotech Stock

Robert F. Service

On Tuesday, 13 January, the price of shares in Geron Corp., a California-based biotech company, rose 44% after news leaked that scientists there and at the University of Texas Southwestern Medical Center had managed to stem the aging process in cultured human cells. By week's end, however, as it became clear that income-generating products of the research are distant, Geron's share price had glided back down. The research, which confirmed that the enzyme telomerase can affect cellular aging, was published in the 16 January issue of Science.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)